M Ventures


M Ventures is the corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Since its 2009 inception it invests with dual strategic and financial objectives into Biotechnology and Technology companies across Healthcare drug development, Life Science tools, Electronics, Frontier Technology and Sustainability. The firm takes an active role in portfolio companies, partnering with entrepreneurs and co-investors to translate innovation toward commercial success.

M Ventures

Amsterdam, Noord-Holland, The Netherlands, Europe


Services

Equity investment (corporate venture capital)

Provides direct equity financing across early and growth stages as a corporate venture fund of Merck KGaA.

Strategic partnership with Merck KGaA

Connects portfolio companies to Merck KGaA's scientific, technical and commercial resources and expertise.

Active portfolio support (board/advisory involvement)

Takes an active role in portfolio companies through regular engagement, strategic and operational advice, and board or advisory support.

Network and fundraising facilitation

Leverages its investor network and internal Merck contacts to support fundraising and introductions to potential partners and hires.


Portfolio

#Healthcare

ML-driven antibody discovery platform; M Ventures led a £35M round (news listed).

#Healthcare / Drug discovery

Develops metasurface optics for optical sensing; partnership activity with large OEMs noted in news.

#Electronics / Optics

Applies physics with AI/ML for semiconductor equipment manufacturers.

#Electronics / Semiconductor equipment ML

Fabless semiconductor company designing Edge AI processors.

#Electronics / Edge AI processors

Spin-off from Merck KGaA; entered agreement to be acquired by Novartis (news).

#Healthcare / Immunotherapy

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.